Presence and vascular pharmacology of KATP channel subtypes in rat central and peripheral tissues

European Journal of Pharmacology

Volumn 637, Issue 1-3, 2010, Pages 109-117

  Ploug, Kenneth Beri ^a   Baun, Michael ^a   Hay Schmidt, Anders ^a   Olesen, Jes ^a   Jansen Olesen, Inger ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

KATP channel; KATP channel blocker; Migraine; MRNA expression; Rat tissue; Vascular pharmacology

Indexed keywords

INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR6.1; MESSENGER RNA; N (1 ADAMANTYL) N' CYCLOHEXYL 4 MORPHOLINECARBOXAMIDINE; SULFONYLUREA RECEPTOR; SULFONYLUREA RECEPTOR 1; SULFONYLUREA RECEPTOR 2B; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BASILAR ARTERY; BRAIN; CHANNEL GATING; COLON; CONTROLLED STUDY; CORONARY ARTERY; DRUG MECHANISM; FEMORAL ARTERY; HEART; KIDNEY; LIVER; LUNG; MALE; MENINGEAL ARTERY; MESENTERIC ARTERY; MIDDLE CEREBRAL ARTERY; MYOGRAPHY; NONHUMAN; PANCREAS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; RENAL ARTERY; TISSUE DISTRIBUTION; TISSUE SPECIFICITY;

ANIMALS; ARTERIES; BINDING SITES; KATP CHANNELS; MALE; MIGRAINE DISORDERS; ORGAN SPECIFICITY; POTASSIUM CHANNEL BLOCKERS; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 77953291041     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2010.03.027     Document Type: Article

References (45)

1. Aguilar-Bryan L., Bryan J. Molecular biology of adenosine triphosphate-sensitive potassium channels. Endocr. Rev. 1999, 20:101-135.
2. Allen T.G., Brown D.A. Modulation of the excitability of cholinergic basal forebrain neurones by KATP channels. J. Physiol. 2004, 554:353-370.
3. Ashina M., Bendtsen L., Jensen R., Olesen J. Nitric oxide-induced headache in patients with chronic tension-type headache. Brain 2000, 123(Pt 9):1830-1837.
4. Babenko A.P., Gonzalez G., Aguilar-Bryan L., Bryan J. Reconstituted human cardiac KATP channels: functional identity with the native channels from the sarcolemma of human ventricular cells. Circ. Res. 1998, 83:1132-1143.
5. Brayden J.E. Functional roles of KATP channels in vascular smooth muscle. Clin. Exp. Pharmacol. Physiol. 2002, 29:312-316.
6. Christiansen I., Thomsen L.L., Daugaard D., Ulrich V., Olesen J. Glyceryl trinitrate induces attacks of migraine without aura in sufferers of migraine with aura. Cephalalgia 1999, 19:660-667.
7. Chutkow W.A., Pu J., Wheeler M.T., Wada T., Makielski J.C., Burant C.F., McNally E.M. Episodic coronary artery vasospasm and hypertension develop in the absence of Sur2 K(ATP) channels. J. Clin. Invest. 2002, 110:203-208.
8. D'Arcy V., Laher M., McCoy D., Sullivan P., Walsh C.H., Hickey M.P. Pinacidil, a new vasodilator, in the treatment of mild to moderate essential hypertension. Eur. J. Clin. Pharmacol. 1985, 28:347-349.
9. Goldberg M.R. Clinical pharmacology of pinacidil, a prototype for drugs that affect potassium channels. J. Cardiovasc. Pharmacol. 1988, 12(Suppl 2):41-47.
10. Gozalov A., Jansen-Olesen I., Klaerke D., Olesen J. Role of K ATP channels in cephalic vasodilatation induced by calcitonin gene-related peptide, nitric oxide, and transcranial electrical stimulation in the rat. Headache 2008, 48:1202-1213.
11. Gribble F.M., Tucker S.J., Seino S., Ashcroft F.M. Tissue specificity of sulfonylureas: studies on cloned cardiac and beta-cell K(ATP) channels. Diabetes 1998, 47:1412-1418.
12. Humphrey S.J., Smith M.P., Cimini M.G., Buchanan L.V., Gibson J.K., Khan S.A., Meisheri K.D. Cardiovascular effects of the K-ATP channel blocker U-37883A and structurally related morpholinoguanidines. Methods Find. Exp. Clin. Pharmacol. 1996, 18:247-260.
13. Jansen-Olesen I., Mortensen C.H., El-Bariaki N., Ploug K.B. Characterization of K(ATP)-channels in rat basilar and middle cerebral arteries: studies of vasomotor responses and mRNA expression. Eur. J. Pharmacol. 2005, 523:109-118.
14. Kakkar R., Ye B., Stoller D.A., Smelley M., Shi N.Q., Galles K., Hadhazy M., Makielski J.C., McNally E.M. Spontaneous coronary vasospasm in KATP mutant mice arises from a smooth muscle-extrinsic process. Circ. Res. 2006, 98:682-689.
15. Kidney J.C., Fuller R.W., Worsdell Y.M., Lavender E.A., Chung K.F., Barnes P.J. Effect of an oral potassium channel activator, BRL 38227, on airway function and responsiveness in asthmatic patients: comparison with oral salbutamol. Thorax 1993, 48:130-133.
16. Kovalev H., Quayle J.M., Kamishima T., Lodwick D. Molecular analysis of the subtype-selective inhibition of cloned KATP channels by PNU-37883A. Br. J. Pharmacol. 2004, 141:867-873.
17. Krabbe A.A., Olesen J. Headache provocation by continuous intravenous infusion of histamine. Clinical results and receptor mechanisms. Pain 1980, 8:253-259.
18. Kruuse C., Thomsen L.L., Jacobsen T.B., Olesen J. The phosphodiesterase 5 inhibitor sildenafil has no effect on cerebral blood flow or blood velocity, but nevertheless induces headache in healthy subjects. J. Cereb. Blood Flow Metab. 2002, 22:1124-1131.
19. Kruuse C., Thomsen L.L., Birk S., Olesen J. Migraine can be induced by sildenafil without changes in middle cerebral artery diameter. Brain 2003, 126:241-247.
20. Lange M., Morelli A., Westphal M. Inhibition of potassium channels in critical illness. Curr. Opin. Anaesthesiol. 2008, 21:105-110.
21. Lassen L.H., Ashina M., Christiansen I., Ulrich V., Grover R., Donaldson J., Olesen J. Nitric oxide synthase inhibition: a new principle in the treatment of migraine attacks. Cephalalgia 1998, 18:27-32.
22. Lassen L.H., Haderslev P.A., Jacobsen V.B., Iversen H.K., Sperling B., Olesen J. CGRP may play a causative role in migraine. Cephalalgia 2002, 22:54-61.
23. Li L., Wu J., Jiang C. Differential expression of Kir6.1 and SUR2B mRNAs in the vasculature of various tissues in rats. J. Membr. Biol. 2003, 196:61-69.
24. Meisheri K.D., Humphrey S.J., Khan S.A., Cipkus-Dubray L.A., Smith M.P., Jones A.W. 4-morpholinecarboximidine-N-1-adamantyl-N'-cyclohexylhydrochloride (U-37883A): pharmacological characterization of a novel antagonist of vascular ATP-sensitive K+ channel openers. J. Pharmacol. Exp. Ther. 1993, 266:655-665.
25. Miki T., Seino S. Roles of KATP channels as metabolic sensors in acute metabolic changes. J. Mol. Cell. Cardiol. 2005, 38:917-925.
26. Morrissey A., Rosner E., Lanning J., Parachuru L., Dhar C.P., Han S., Lopez G., Tong X., Yoshida H., Nakamura T.Y., Artman M., Giblin J.P., Tinker A., Coetzee W.A. Immunolocalization of KATP channel subunits in mouse and rat cardiac myocytes and the coronary vasculature. BMC Physiol. 2005, 5:1.
27. Nyborg N.C., Baandrup U., Mikkelsen E.O., Mulvany M.J. Active, passive and myogenic characteristics of isolated rat intramural coronary resistance arteries. Pflugers Arch. 1987, 410:664-670.
28. Olesen J., Iversen H.K., Thomsen L.L. Nitric oxide supersensitivity: a possible molecular mechanism of migraine pain. Neuroreport 1993, 4:1027-1030.
29. Olesen J., Diener H.C., Husstedt I.W., Goadsby P.J., Hall D., Meier U., Pollentier S., Lesko L.M. Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine. N. Engl. J. Med. 2004, 350:1104-1110.
30. Perricone S.C., Humphrey S.J., Skaletzky L.L., Graham B.E., Zandt R.A., Zins G.R. Synthesis and diuretic activity of alkyl- and arylguanidine analogs of N, N'-dicyclohexyl-4-morpholinecarboxamidine in rats and dogs. J. Med. Chem. 1994, 37:3693-3700.
31. Petersen K.A., Lassen L.H., Birk S., Lesko L., Olesen J. BIBN4096BS antagonizes human alpha-calcitonin gene related peptide-induced headache and extracerebral artery dilatation. Clin. Pharmacol. Ther. 2005, 77:202-213.
32. Ploug K.B., Edvinsson L., Olesen J., Jansen-Olesen I. Pharmacological and molecular comparison of K(ATP) channels in rat basilar and middle cerebral arteries. Eur. J. Pharmacol. 2006, 553:254-262.
33. Ploug K.B., Boni L.J., Baun M., Hay-Schmidt A., Olesen J., Jansen-Olesen I. K(ATP) channel expression and pharmacological in vivo and in vitro studies of the K(ATP) channel blocker PNU-37883A in rat middle meningeal arteries. Br. J. Pharmacol. 2008, 154:72-81.
34. Ploug K.B., Sorensen M.A., Strobech L., Klaerke D.A., Hay-Schmidt A., Sheykhzade M., Olesen J., Jansen-Olesen I. K ATP channels in pig and human intracranial arteries. Eur. J. Pharmacol. 2008, 601:43-49.
35. Schwanstecher M., Sieverding C., Dorschner H., Gross I., Aguilar-Bryan L., Schwanstecher C., Bryan J. Potassium channel openers require ATP to bind to and act through sulfonylurea receptors. Embo J. 1998, 17:5529-5535.
36. Schytz H.W., Birk S., Wienecke T., Kruuse C., Olesen J., Ashina M. PACAP38 induces migraine-like attacks in patients with migraine without aura. Brain 2009, 132:16-25.
37. Seino S. ATP-sensitive potassium channels: a model of heteromultimeric potassium channel/receptor assemblies. Annu. Rev. Physiol. 1999, 61:337-362.
38. Sterndorff B., Johansen P. The antihypertensive effect of pinacidil versus prazosin in mild to moderate hypertensive patients seen in general practice. Acta Med. Scand. 1988, 224:329-336.
39. Surah-Narwal S., Xu S.Z., McHugh D., McDonald R.L., Hough E., Cheong A., Partridge C., Sivaprasadarao A., Beech D.J. Block of human aorta Kir6.1 by the vascular KATP channel inhibitor U37883A. Br. J. Pharmacol. 1999, 128:667-672.
40. Suzuki S., Yano K., Kusano S., Hashimoto T. Antihypertensive effect of levcromakalim in patients with essential hypertension. Study by 24-h ambulatory blood pressure monitoring. Arzneimittelforschung 1995, 45:859-864.
41. Wienecke T., Olesen J., Oturai P.S., Ashina M. Prostacyclin (epoprostenol) induces headache in healthy subjects. Pain 2008, 139:106-116.
42. Wienecke T., Olesen J., Ashina M. Prostaglandin I(2) (epoprostenol) triggers migraine-like attacks in migraineurs. Cephalalgia. 2009 Jul 9. (Electronic publication ahead of print). 2009.
43. Williams A.J., Lee T.H., Cochrane G.M., Hopkirk A., Vyse T., Chiew F., Lavender E., Richards D.H., Owen S., Stone P., et al. Attenuation of nocturnal asthma by cromakalim. Lancet 1990, 336:334-336.
44. Yamada K., Inagaki N. Neuroprotection by KATP channels. J. Mol. Cell. Cardiol. 2005, 38:945-949.
45. Zhou M., He H.J., Suzuki R., Liu K.X., Tanaka O., Sekiguchi M., Itoh H., Kawahara K., Abe H. Localization of sulfonylurea receptor subunits, SUR2A and SUR2B, in rat heart. J. Histochem. Cytochem. 2007, 55:795-804.